Skip to main content

News Archive

News Archive - School of Medicine

UC San Diego Moores Cancer Center Receives Prestigious $25 Million Grant

June 17, 2026

The grant provides continuing support for the Comprehensive Cancer Center’s cutting‑edge research and increases access to innovative cancer therapies across the San Diego region.

UC San Diego Researchers Receive Major Grants as Part of $50M Effort to Advance Women’s Brain Health

June 16, 2026

New grants to UC San Diego researchers will help them explain why women are more likely to get Alzheimer's disease and develop new risk-prediction tools for clinicians.

New MasterClass at Moores Cancer Center Accelerates the Path from Discovery to Impact

June 16, 2026

A new training program at UC San Diego Moores Cancer Center is preparing scientists and physicians the ins and outs of industry, helping them bring promising ideas to patients faster.

Genetic Mapping Identifies Potential New Targets for Cocaine Addiction

June 11, 2026

UC San Diego researchers have identified genetic drivers of cocaine addiction, uncovering a potential new treatment target in the liver. This large-scale study maps how metabolism influences addiction-like behavior to bridge the gap to human medicine.

Homegrown Healers

June 9, 2026

The University of California San Diego School of Medicine celebrated its 55th Doctor of Medicine graduating class on May 31, 2026. As the new physicians crossed the stage, family and friends beamed with pride, reflecting on the years of dedication that led to this milestone moment.

Gene Therapy Approach Reduces Muscle Spasticity After Chronic Spinal Cord Injury

June 9, 2026

New research suggests that a single administration of spinal segment-targeted gene therapy may provide a long-lasting strategy for reducing muscle spasticity caused by spinal cord injury and potentially other neurological conditions associated with abnormal muscle tone.

Study: Popular GLP-1 Drug May Slow Down Biological Aging

June 2, 2026

A study by UC San Diego researchers and their colleagues has found that semaglutide slows down the accumulation of biological aging markers in the DNA of adults with HIV, pointing to the potential of GLP‑1 receptor agonists to help prevent age‑related diseases.

US Overdose Deaths Dropped in 2024 Amid Uneven Progress, Study Finds

June 2, 2026

U.S. overdose death rates declined between 2023 and 2024, marking the first recorded drop in all four waves of the nation’s overdose crisis. However, overdose deaths involving stimulants without fentanyl, and xylazine-related deaths, continue to rise and racial disparities remain severe.

UC San Diego Study Uncovers Molecular “Shield” Behind Cancer Immunotherapy Resistance

June 1, 2026

UC San Diego researchers discovered that blocking microRNA-25 reshapes the tumor immune environment and improves responses to cancer immunotherapy.

Naturally Occurring Molecule May Help Outsmart Melanoma

May 27, 2026

Researchers from UC San Diego have uncovered a new possibility for treating melanoma, and it's something we have in our bodies already.
Category navigation with Social links